Home Business & Finance Stock market: McKesson share price down – 01/14/22 – News

Stock market: McKesson share price down – 01/14/22 – News

Stock market: McKesson share price down - 01/14/22 - News

Friday, 01/14/2022 5:50 p.m. from ARIVA.DE | Views: 40 The performance overview of a share (icon image). © pixabay.com Trade S&P 500 shares permanently for 0 euros! Now on Smartbroker.de In US securities trading, the McKesson share (McKesson share) is lighter at the moment. Most recently, investors paid $252.99 for the paper. McKesson’s shares are currently down 0.69 percent. The stock fell $1.76. The security is currently priced at $252.99. Despite the drop, McKesson’s stock is ahead of the S&P 500 (S&P 500). The S&P 500 currently only has 4,625 points. This corresponds to a minus of 0.84 percent. Despite today’s price loss: McKesson’s stock is currently still a long way from its all-time low. On January 19, 2012, the stock closed at $74.89, down 70.40 percent from the current price.

The McKesson company

McKesson Corporation is an American provider specializing in healthcare and medical technology. The company sells medicines, pharmaceutical products, technical solutions for health management and information management, as well as supplementary services designed to help reduce costs and increase quality in the healthcare sector. With its comprehensive range of products, the group is one of the largest suppliers in North America. McKesson closed the past financial year with a loss of 4.54 billion US dollars. The turnover of the company was 238 billion US dollars. McKesson intends to announce the latest business figures on February 2, 2022.

These are the most searched stocks of the past few days

ARIVA.DE offers price information from all relevant stock exchanges around the world. The following table shows which titles were last most frequently searched for by users. Read more This article was created by ARIVA.DE using standardized company information from Finance Base. Advertisement Subscribe to more news about the GlaxoSmithKline share free of charge Note: ARIVA.DE publishes analyses, columns and news from various sources in this section. ARIVA.DE AG is not responsible for content that has been posted by third parties in the “News” area of ​​this website and does not adopt it as its own. This content can be identified in particular by a corresponding “from” label below the article heading and/or by the link “To read the full article, please click here.”; The named third party is solely responsible for this content.

Other users were also interested in this article:

#Stock #market #McKesson #share #price #News


Please enter your comment!
Please enter your name here

4 + 18 =